arrow
B

Bogusław Nedoszytko

Medical University of Gdańsk
H指数:35
被引数:5,628

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
2024-04-234
PRE
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
2023-06-014
OAAI
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
2022-08-0113
OAAI
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
2022-08-0115
OAAI
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
2022-08-0147
OAAI
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
2022-08-0134
OAAI
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
2021-11-01169
OAAI
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
2021-11-0139
OAAI
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
2021-06-0135
OAAI
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
2020-08-0126
OAAI
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
2019-12-0197
OAAI
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
2019-04-01152
OAAI
Interleukin-31 Polymorphisms and Serum IL-31 Level in Patients with Mastocytosis: Correlation with Clinical Presentation and Pruritus

肥大细胞增多症患者的Interleukin-31多态性和血清IL-31水平: 与临床表现和瘙痒的相关性

2017-01-0126
OAAI